全文获取类型
收费全文 | 31911篇 |
免费 | 3292篇 |
国内免费 | 109篇 |
专业分类
耳鼻咽喉 | 270篇 |
儿科学 | 1097篇 |
妇产科学 | 780篇 |
基础医学 | 4523篇 |
口腔科学 | 657篇 |
临床医学 | 4395篇 |
内科学 | 6756篇 |
皮肤病学 | 676篇 |
神经病学 | 3092篇 |
特种医学 | 789篇 |
外国民族医学 | 4篇 |
外科学 | 3537篇 |
综合类 | 414篇 |
一般理论 | 11篇 |
预防医学 | 3211篇 |
眼科学 | 490篇 |
药学 | 2200篇 |
中国医学 | 20篇 |
肿瘤学 | 2390篇 |
出版年
2023年 | 278篇 |
2022年 | 421篇 |
2021年 | 846篇 |
2020年 | 664篇 |
2019年 | 1017篇 |
2018年 | 1124篇 |
2017年 | 908篇 |
2016年 | 956篇 |
2015年 | 1013篇 |
2014年 | 1198篇 |
2013年 | 1690篇 |
2012年 | 2195篇 |
2011年 | 2131篇 |
2010年 | 1351篇 |
2009年 | 1196篇 |
2008年 | 1809篇 |
2007年 | 1832篇 |
2006年 | 1715篇 |
2005年 | 1656篇 |
2004年 | 1511篇 |
2003年 | 1430篇 |
2002年 | 1307篇 |
2001年 | 466篇 |
2000年 | 476篇 |
1999年 | 449篇 |
1998年 | 331篇 |
1997年 | 291篇 |
1996年 | 234篇 |
1995年 | 236篇 |
1994年 | 226篇 |
1993年 | 191篇 |
1992年 | 277篇 |
1991年 | 264篇 |
1990年 | 249篇 |
1989年 | 238篇 |
1988年 | 221篇 |
1987年 | 202篇 |
1986年 | 202篇 |
1985年 | 214篇 |
1984年 | 175篇 |
1983年 | 165篇 |
1982年 | 142篇 |
1981年 | 140篇 |
1980年 | 100篇 |
1979年 | 138篇 |
1978年 | 104篇 |
1977年 | 116篇 |
1976年 | 108篇 |
1973年 | 108篇 |
1972年 | 98篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.6.
Renaud Snanoudj Nassim Kamar Elisabeth Cassuto Sophie Caillard Marie Metzger Pierre Merville Antoine Thierry Isabelle Jollet Philippe Grimbert Dany Anglicheau Marc Hazzan Gabriel Choukroun Bruno Hurault De Ligny Bénedicte Janbon Vincent Vuiblet Anne Devys Yann Le Meur Michel Delahousse Jean-Luc Taupin 《Kidney international》2019,95(6):1471-1485
7.
This is the third and final part of a series of articles that report the findings of a study that investigated the effects of a summer externship program on the transition into a professional role among nurses who participated in a summer nurse externship program at an acute care pediatric hospital. Specifically, this article reports the retention and recruitment benefits of a summer nurse externship program for the institution from 1998 through 2003. A total of 153 externs out of the 193 (79.0%) assumed a registered nurse position at the institution, and 77% remained in that role for 12 months. Overall, the nurse extern program for this institution appeared to be an effective recruitment and retention strategy that is on par with the institution and national data for retention and turnover data. 相似文献
8.
9.
10.
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
Bayard L. Powell Hyman B. Muss Robert L. Capizzi Mary E. Caponera Douglas R. White Patricia J. Zekan James N. Atkins Don V. Jackson Jr. Frederick Richards II John B. Craig Julia M. Cruz Charles L. Spurr 《Cancer chemotherapy and pharmacology》1987,19(3):250-252
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182 相似文献